CARI Health, Inc. — SEC Form D Filing
CARI Health, Inc. filed an SEC Form D on November 6, 2026, reporting $280K raised in Biotechnology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- November 6, 2026
- Amount reported
- $280K
- Round stage
- Seed stage due to raising $280,000 via convertible notes alongside significant non-dilutive grant funding to advance clinical development.
- Industry
- Biotechnology
- Website
- https://www.carihealth.com
What the company does
Securities: Convertible Promissory Notes. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Clinicians treating opioid use disorder lack rapid diagnostic tools to measure methadone metabolism at the point of care, resulting in slow dosing stabilization and suboptimal patient retention.
Solution
CARI Health develops a finger-stick point-of-care blood testing system that measures methadone concentration and metabolism in roughly 15 minutes to enable precise, personalized dosing.
Why now
The escalating national opioid crisis and advancements in micro-volume blood diagnostic sensors have created an urgent imperative for rapid, data-driven addiction treatment tools.
Source: SEC EDGAR Form D filing